Notably, Lf has been reported to cross the BBB via the lactoferrin receptor (LfR), which is expressed on bECs and is overexpressed in glioma cells, making it an attractive ligand for brain-targeted drug delivery [330]. The gene discussed is ITLN1; the disease is central nervous system cancer.